Print Page   |   Sign In   |   Join!
News & Press
Filter news by category:

PSHP Newsletters

Displaying page 2 of 2
1  |  2

Student Submissions
Monday, May 16, 2016   (0 Comments - view/add)
Naloxone: A Lifesaving Antidote in the Epidemic of Opioid Substance »
Jennifer Nguyen, PharmD Candidate 2017 Jasica Truong, PharmD Candidate 2018 Jennifer Andres, PharmD, BCPS Temple Un...
Monday, April 18, 2016   (0 Comments - view/add)
Novel Combination Drug Takes on Heart Failure »
Novel Combination Drug Takes On Heart Failure   Joyce Gambrah, PharmD Candidate 2017 Stacy Pasciolla, Pharm...
Wednesday, April 6, 2016   (0 Comments - view/add)
Temple University School of Pharmacy Flash Mob for Medication Awareness »
March 18, 2016 The Temple University School of Pharmacy is full of smart students, but did you know they can also dance...
Friday, March 25, 2016   (0 Comments - view/add)
SSHP/TUSPAA Mentor Night a Success! »
Peter Nikolos & Jola Salavaci, Pharm.D. Candidates 2017  On Thursday, March 10th, 2016, the Temple Universi...
Tuesday, February 23, 2016   (0 Comments - view/add)
Tagrisso »
Tagrisso ® : The First Agent Approved for the Treatment of Metastatic Epidermal Growth Factor Receptor T790M Mutation-Po...
Tuesday, February 23, 2016   (0 Comments - view/add)
Veltassa; Worth the 50-Year Wait? »
Veltassa TM ; Worth the 50-Year Wait? Tenielle Watkins, PharmD Candidate 2017 Oxana Placinta, PharmD Candidat...
Thursday, January 21, 2016   (0 Comments - view/add)
ASHP Midyear Clinical Meeting 2015 – A Student Perspective »
ASHP Midyear Clinical Meeting 2015 – A Student Perspective Brett Healy, Pharm.D. Candidate 2016 John Marasigan, Pharm....
Thursday, January 21, 2016   (0 Comments - view/add)
An Overview of PCSK9 Inhibitors »
Oludamilola Olugbile PhamD Candidate 2016 Jefferson College of Pharmacy   Donna Peterson PharmD C...
Monday, December 7, 2015   (0 Comments - view/add)
Praxbind®: The First Specific Reversal Agent for the Oral Anticoagulant, Pradaxa® »
Praxbind ® : The First Specific Reversal Agent for the Oral Anticoagulant, Pradax a ®   Taylor Gibbs, P...
Thursday, November 12, 2015   (0 Comments - view/add)
PSHP Student Submission - The Daraprim Controversy: Facts and Media Frenzy »
The Daraprim Controversy: Facts and Media Frenzy Sophie Hien Le, PharmD candidate 2017 Paris Rezai, PharmD cand...
Thursday, October 22, 2015   (0 Comments - view/add)
Student Submission: Savaysa®: A New Anticoagulant for the Treatment of Nonvalvular Atrial Fibrillati »
Savaysa®: A New Anticoagulant for the Treatment of Nonvalvular Atrial Fibrillation   Christine Hancock, Ph...
Thursday, September 17, 2015   (0 Comments - view/add)
Entyvio®: A new option for patients with inflammatory bowel disease »
Entyvio®: A new option for patients with inflammatory bowel disease Amanda Gerberich, PharmD Candidate 2017 Miche...
Wednesday, July 15, 2015
AfrezzaⓇ: Inhaled Rapid-Acting Insulin for the Treatment of Diabetes Mellitus in Adults »
Afrezza Ⓡ : Inhaled Rapid-Acting Insulin for the Treatment of Diabetes Mellitus in Adults Kimberly Pough, PharmD...

Displaying page 2 of 2
1  |  2

Membership Management Software Powered by YourMembership  ::  Legal